Lukang Pharmaceutical's net profit increased by 245% year-on-year last year

Business Club March 14 News March 12, Lukang Pharmaceutical released the 2010 annual report, the company achieved total revenue of 2.196 billion yuan last year, an increase of 10.63% compared with the same period in 2009; total profit of 151 million yuan, an increase of 228.37%; The net profit attributable to the shareholders of the listed company was 129 million yuan, an increase of 244.89% year-on-year; and the basic earnings per share was 0.22 yuan.

Lukang Pharmaceutical Co., Ltd. stated that the significant increase in its performance during the reporting period was mainly due to a virtuous cycle of production and sales, and a significant increase in the production load rate. However, Lukang Pharmaceutical, which has always been known as the “iron rooster”, has not shown any signs of detachment from the team. It stated that it is currently carrying out technical reconstruction projects and has a large demand for production and operation funds. It does not make any kind of dividends.

Through comparison with last year's three quarterly reports, it was discovered that the tradable shareholders of Lukang Pharmaceuticals have undergone enormous changes in the fourth quarter of last year, and individual investors have replaced institutions and become the main market force of Lukang Pharmaceutical in the fourth quarter of last year. According to the top 10 list of shareholders who are not subject to sales restrictions, the three SWFs that were stationed in the second quarter and third quarter of last year have all withdrawn from the top ten in the fourth quarter of last year. The four natural person shareholders, including super retailer Li Bin, who had fought in Maohua Shihua in the first half of last year, rushed into shares in Lukang Pharmaceuticals in the fourth quarter of last year. (Author: Miao Hui)